Dr. Vikash Kumar Sinha, MD

Dr. Sinha practices at Methodist Southlake Medical Center in Southlake, Texas, part of Methodist Hospitals of Dallas.

Dr. Sinha's NPI, 1740628726, was assigned on June 12, 2013. Dr. Sinha holds Indiana license 01074975A.

Dr. Sinha's primary practice is Methodist Southlake Medical Center, at 421 E State Highway 114, Southlake, TX 76092 in Tarrant County. The practice phone is (878) 654-4400. Dr. Sinha also practices at Methodist Southlake Hospital, 8701 Broadway, Merrillville, IN 46410.

Dr. Sinha's primary practice is Methodist Southlake Medical Center in Southlake, Texas, part of Methodist Hospitals of Dallas. Dr. Sinha is also affiliated with Northwestern Medicine Central DuPage Hospital. The medical group on file is Kidney Care Center. Dmand AI also links Dr. Sinha to 3 more hospitals, 2 dialysis centers, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sinha practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Sinha's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Sinha's licenses on file in 2 states: Indiana and Illinois.

CMS data shows 3,491 Medicare services from Dr. Sinha across 15 procedure codes in 2024, for 506 Medicare patients. Medicare paid $274,542 for them.

CMS counts 506 Medicare patients who saw Dr. Sinha in 2024. The largest group is 65 to 74, with 172 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 27% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sinha's median patient age at 72, with 51% women.

In 2024, Dr. Sinha wrote 3,020 Medicare Part D claims for 489 patients. 87% of them were for generic drugs. CMS names the drug for 2,676 of them, across 51 drugs with 11 or more claims each, at $359,027 in total drug cost. In 2023, CMS named 2,716 claims across 58 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Sinha for performance year 2024, reported individually. Dr. Sinha accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 79 general payments to Dr. Sinha from 17 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 47% of the total. Relypsa, Inc. paid the most, $12,968.